The Clinical Core of the Program Project Grant will perform the cognitive and clinical assessments of allsubjects for the program project grant (PPG). The Clinical Core will identify and assess normal subjects,subjects with mild cognitive impairment (MCI), patients at appropriate stages of Alzheimer's disease (mild, moderate and severe, according to level of Mini Mental State Examination score), and patients with Parkinson's Disease, Dementia of Parkinson's Disease, and Dementia with Lewy Bodies. These cases will be referred from the Alzheimer's Disease Research Center (ADRC) at the University fo Pittsburgh and the Movement Disorders Clinics (MvtDCs) of the Pittsburgh VA Health System and the Parkinson's Center of Excellence in the Department of Neurology, University of Pittsburgh. The Core will review the study protocols with potential subjects to provide full informed consent, perform the cognitive, motor, and other assessments necessary for the protocol, and coordinate patient appointments for the imaging studies of the protocols. Follow-up appointments and ongoing telephone contacts with the subjects in the longitudinal portion of the study will be maintained by the core. The Clinical Core will coordinate with the ADRC and the MvtDCs to assure accurate and timely transfer of clinical information, cognitive scores, and other relevant data to the PPG data set, and subsequently to the Imaging/Methodology/Statistics (IMS) core for data analyses and correlation with PET and MRI data. The PPG Coordinating Committee, comprised of the PIs of the Clinical Core, the Imaging, Methodology and Statistics (IMS) Core, the PIs and CoPIs of the three projects, and the PPG Administrator, will oversee the Clinical Core. All of the investigators in this Core and all of the individuals with whom they interact to achieve the aims of the core have worked together for many years, adding to the assurance that the proposed work will be carried out appropriately.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
1P01AG025204-01
Application #
6887210
Study Section
Special Emphasis Panel (ZAG1-ZIJ-4 (O6))
Project Start
2004-12-01
Project End
2009-11-30
Budget Start
2004-12-01
Budget End
2006-04-30
Support Year
1
Fiscal Year
2005
Total Cost
$58,753
Indirect Cost
Name
University of Pittsburgh
Department
Type
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Hu, Ziheng; Wang, Lirong; Ma, Shifan et al. (2018) Synergism of antihypertensives and cholinesterase inhibitors in Alzheimer's disease. Alzheimers Dement (N Y) 4:542-555
Zhao, Yujing; Tudorascu, Dana L; Lopez, Oscar L et al. (2018) Amyloid ? Deposition and Suspected Non-Alzheimer Pathophysiology and Cognitive Decline Patterns for 12 Years in Oldest Old Participants Without Dementia. JAMA Neurol 75:88-96
Jansen, Willemijn J; Ossenkoppele, Rik; Tijms, Betty M et al. (2018) Association of Cerebral Amyloid-? Aggregation With Cognitive Functioning in Persons Without Dementia. JAMA Psychiatry 75:84-95
Wilckens, Kristine A; Tudorascu, Dana L; Snitz, Beth E et al. (2018) Sleep moderates the relationship between amyloid beta and memory recall. Neurobiol Aging 71:142-148
Minhas, Davneet S; Price, Julie C; Laymon, Charles M et al. (2018) Impact of partial volume correction on the regional correspondence between in vivo [C-11]PiB PET and postmortem measures of A? load. Neuroimage Clin 19:182-189
Yan, Qi; Nho, Kwangsik; Del-Aguila, Jorge L et al. (2018) Genome-wide association study of brain amyloid deposition as measured by Pittsburgh Compound-B (PiB)-PET imaging. Mol Psychiatry :
La Joie, Renaud; Ayakta, Nagehan; Seeley, William W et al. (2018) Multisite study of the relationships between antemortem [11C]PIB-PET Centiloid values and postmortem measures of Alzheimer's disease neuropathology. Alzheimers Dement :
Cohen, Ann D; McDade, Eric; Christian, Brad et al. (2018) Early striatal amyloid deposition distinguishes Down syndrome and autosomal dominant Alzheimer's disease from late-onset amyloid deposition. Alzheimers Dement 14:743-750
Marquié, Marta; Normandin, Marc D; Meltzer, Avery C et al. (2017) Pathological correlations of [F-18]-AV-1451 imaging in non-alzheimer tauopathies. Ann Neurol 81:117-128
Mi, Zhiping; Abrahamson, Eric E; Ryu, Angela Y et al. (2017) Loss of precuneus dendritic spines immunopositive for spinophilin is related to cognitive impairment in early Alzheimer's disease. Neurobiol Aging 55:159-166

Showing the most recent 10 out of 106 publications